Kurt W. Vogel - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kurt W. Vogel

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Current Chemical Genomics|February 18, 2010

Fluorescent cascade and direct assays for characterization of RAF signaling pathway inhibitorsKevin R Kupcho, Rica Bruinsma, Tina M Hallis, et al.

Journal of Biomolecular Screening|July 1, 2009

Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platformConnie S Lebakken, Steven M Riddle, Upinder Singh, et al.

Current Chemical Genomics|February 18, 2010

Homogenous fluorescent assays for characterizing small-molecule activators of AMP-activated protein kinase (AMPK)Laurie J Reichling, Steven M Riddle, Baigen Mei, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 5, 2014

Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domainJingling Liao, Chun-Xiang Wu, Christopher Burlak, et al.

Assay and Drug Development Technologies|May 13, 2008

Development of the predictor HERG fluorescence polarization assay using a membrane protein enrichment approachDavid R Piper, Steve R Duff, Hildegard C Eliason, et al.

Cancer Research|April 12, 2013

Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosisThomas O'Hare, Christopher A Eide, Anupriya Agarwal, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Current Chemical Genomics|February 18, 2010

Fluorescent cascade and direct assays for characterization of RAF signaling pathway inhibitorsKevin R Kupcho, Rica Bruinsma, Tina M Hallis, et al.

Journal of Biomolecular Screening|July 1, 2009

Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platformConnie S Lebakken, Steven M Riddle, Upinder Singh, et al.

Current Chemical Genomics|February 18, 2010

Homogenous fluorescent assays for characterizing small-molecule activators of AMP-activated protein kinase (AMPK)Laurie J Reichling, Steven M Riddle, Baigen Mei, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 5, 2014

Parkinson disease-associated mutation R1441H in LRRK2 prolongs the "active state" of its GTPase domainJingling Liao, Chun-Xiang Wu, Christopher Burlak, et al.

Assay and Drug Development Technologies|May 13, 2008

Development of the predictor HERG fluorescence polarization assay using a membrane protein enrichment approachDavid R Piper, Steve R Duff, Hildegard C Eliason, et al.

Cancer Research|April 12, 2013

Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosisThomas O'Hare, Christopher A Eide, Anupriya Agarwal, et al.

Pageof 3